Stock listing
MRK Stock Price, News, Filings & Events — Merck & Company, Inc.
Selected listing: MRK · NEO · CAD · CA
This page tracks Merck & Company, Inc.'s MRK:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MRK:NEO. MRK:NEO is the stock-level entry point for investors researching Merck & Company, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Merck & Company, Inc. (ticker: MRK) is a leading American pharmaceutical company with a market capitalization of approximately $323.72 billion. The company is known for its innovative healthcare solutions and commitment to improving patient outcomes. Merck develops a wide range of prescription medicines, vaccines, and biologic therapies.

- Ticker
- MRK:NEO
- Asset type
- Stock
- Market cap
- $321.57B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NEO
- Currency
- CAD
Merck & Company, Inc. MRK:NEO stock context
This page tracks Merck & Company, Inc.'s MRK:NEO listing on NEO in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MRK:NEO. MRK:NEO is the stock-level entry point for investors researching Merck & Company, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Merck & Company, Inc. (ticker: MRK) is a leading American pharmaceutical company with a market capitalization of approximately $323.72 billion. The company is known for its innovative healthcare solutions and commitment to improving patient outcomes. Merck develops a wide range of prescription medicines, vaccines, and biologic therapies.
Research Merck & Company, Inc.
Merck & Company, Inc. investor report
Review AI stock analysis and investor report context for MRK:NEO.
Merck & Company, Inc. company profile
View the public company page for Merck & Company, Inc. on 6ix.
Merck & Company, Inc. news
Read company news and market updates connected to Merck & Company, Inc..
Merck & Company, Inc. investor events
Find investor webinars, events, and replay context for Merck & Company, Inc..
Alternate listings
MRK:NYSE
US · USD
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
6MK:GETTEX
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
MRK:BCBA
AR · ARS
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
6MK:XETR
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
6MK:TRADEGATE
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
MRK:BMV
MX · MXN
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
MRKD:BCBA
AR · USD
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
MRCK34:BMFBOVESPA
BR · BRL
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
1MRKX:MIL
IT · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
MRK:TSX
CA · CAD
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
A0YD8Q:LSX
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.
6MK:FWB
DE · EUR
Alternate listing for Merck & Company, Inc.; the primary context on this page is MRK:NEO.